Galafold 123 MG
Ended Awarded
- Contract number
- 36C24524N0702
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 5 (VISN 5), to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the delivery of Galafold 123 mg, an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder.
The contract is a delivery order under the General Services Administration's (GSA) Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, with a firm fixed price of $21,089.47 and a completion date of July 5, 2024. This delivery order is part of a multiple-award, indefinite-delivery vehicle that Amicus Therapeutics US, LLC has been awarded to supply Galafold capsules to VHA facilities and service networks nationwide. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C24524N0702?
36C24524N0702 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 2, 2024.
How much is contract 36C24524N0702 worth?
The government has obligated $21,089 on 36C24524N0702.
Is contract 36C24524N0702 an order under another contract?
Yes. 36C24524N0702 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0702 competed?
The extent of competition for 36C24524N0702 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award